Skip to main content
. Author manuscript; available in PMC: 2024 Jan 4.
Published in final edited form as: J Drug Issues. 2022 Aug 2;53(2):296–320. doi: 10.1177/00220426221109948

Table 5.

Regression Results for MAT Utilization Among Courts that Authorize MAT.

Outcome Predictor Level b Incidence Rate
Ratio
SE z p
Number of participants receiving MAT n = 291 courts Intercept −3.08 0.34 −9.19 <0.001
Court type Court 0.037 1.04 0.11 0.34 0.73
Offer MAT choice Court 0.28 1.33 0.054 5.26 <0.001
Drug overdose mortality rate/100k County 0.020 1.02 0.01 2.82 <0.01
Medicaid expansion State 0.21 1.24 0.25 0.85 0.40
State mandates eligibility criteria State −0.68 0.51 0.23 −2.90 <0.01